Congress could tweak patent laws to bring down drug costs
Congress could tweak patent laws to bring down drug costs Herald-Whig Full coverage
In: PATENT NEWS
Congress could tweak patent laws to bring down drug costs Herald-Whig Full coverage
In: PATENT NEWS
CEL-SCI Corp (CVM) Announces US Patent Office Allows New Patent For LEAPS Vaccine Platform Technology StreetInsider.com Full coverage
In: PATENT NEWS
Walgreens awarded patent for its Connected Care Oncology program Pharmacy Today, American Pharmacists Association, pharmacist.com Full coverage
In: PATENT NEWS
Tom Kulik is an Intellectual Property & Information Technology Partner at the Dallas-based law firm of Scheef & Stone, LLP. In private practice for over 20 years, Tom is a sought-after technology lawyer who uses his industry experience as a former computer systems engineer to creatively counsel and …
In: PATENT NEWS
A gaggle of law firms—large Am Law firms and local boutiques alike—have been busily minting new partners in Atlanta. … Carroll handles IP litigation, focused on pharma and biotech-related patents. … Spier practices intellectual property law, focused on patent and trademark procurement. That follows …
In: PATENT NEWS
Not a lot of case law is going through the appeals court, but so far it appears appellate courts see their hands tied by the Alice decision. That said, several early cases have been examples of companies basically trying to patent mathematical algorithms, which aren’t patentable. So there is still... Continue reading
In: PATENT NEWS
Law360, New York (January 29, 2018, 3:59 PM EST) — The owners of patent applications that were diverted into a secret, now-defunct patent screening process lost their latest contract suit against the U.S. Patent and Trademark Office on Friday, with the U.S. Court of Federal Claims finding it had already …
In: PATENT NEWS
Law360, New York (January 29, 2018, 3:27 PM EST) — Paul Hastings LLP convinced the U.S. Patent Trial and Appeal Board to invalidate a major patent covering AbbVie’s $16 billion biologic Humira and uphold four patents covering an Acorda Therapeutics Inc. multiple sclerosis drug, landing the firm a …
In: PATENT NEWS
The TC Heartland decision, which held that a domestic corporation “resides” only in its state of incorporation, upended nearly 30 years of precedent in patent law and dramatically restricted where patent cases may be litigated. Previously, the rules for where a patent infringement lawsuit could be filed …
In: PATENT NEWS
The 2017 U.S. News & World Report’s America’s Best Graduate Schools ranks John Marshall’s Lawyering Skills Program 5th, its Trial Advocacy Program 19th and its Intellectual Property Law Program 21st in the nation. Since its inception, John Marshall has been a pioneer in legal education and has …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION